{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:35:10Z","timestamp":1790994910929,"version":"4.1.0"},"reference-count":28,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2013,2,6]],"date-time":"2013-02-06T00:00:00Z","timestamp":1360108800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Testing and Analysis"],"published-print":{"date-parts":[[2013,7]]},"abstract":"<jats:p>Meconium drug testing is a non\u2010invasive method to detect prenatal drug exposure, which can cause severe problems for the infant, indicating the need for follow\u2010up measures to ensure the welfare of the child. Meconium samples for drug testing were collected from 143 infants as part of routine clinical work among addicted mothers. The drug testing findings were combined with medical records including clinical background and follow\u2010up data. The substances screened for included medicinal opioids, 6\u2010monoacetylmorphine (a metabolite of heroin), amphetamines and tetrahydrocannabinolic acid. At least one of the 13 target drugs was detected in 57 (40%) meconium samples. In 21 cases, the findings were unexpected on the basis of clinical data or denied by the mother. Medicinal opioids, especially the opioid substitution treatment drugs buprenorphine and methadone, comprised the majority of the findings of both admitted and unexpected drug misuse. Meconium drug testing methods should target not just traditional illicit drugs but also prescription drugs with misuse potential. Copyright \u00a9 2013 John Wiley &amp; Sons, Ltd.<\/jats:p>","DOI":"10.1002\/dta.1459","type":"journal-article","created":{"date-parts":[[2013,2,6]],"date-time":"2013-02-06T21:12:42Z","timestamp":1360185162000},"page":"529-533","source":"Crossref","is-referenced-by-count":10,"title":["Meconium drug testing reveals maternal misuse of medicinal opioids among addicted mothers"],"prefix":"10.1002","volume":"5","author":[{"given":"Terhi","family":"Launiainen","sequence":"first","affiliation":[{"name":"Hjelt Institute, Department of Forensic Medicine University of Helsinki  Helsinki Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irmeli","family":"Nupponen","sequence":"additional","affiliation":[{"name":"Hospital for Children and Adolescents Helsinki University Central Hospital  Helsinki Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erja","family":"Halmesm\u00e4ki","sequence":"additional","affiliation":[{"name":"Hospital for Children and Adolescents Helsinki University Central Hospital  Helsinki Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilkka","family":"Ojanper\u00e4","sequence":"additional","affiliation":[{"name":"Hjelt Institute, Department of Forensic Medicine University of Helsinki  Helsinki Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,2,6]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1754.2002.00724.x"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)17865-9"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1998.93710338.x"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2134(96)00014-2"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e31815c14ce"},{"key":"e_1_2_5_7_1","volume-title":"Maternal, Fetal and Neonaltal Physiology: A Clinical Perspective","author":"Blackburn S.","year":"2003"},{"key":"e_1_2_5_8_1","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1093\/clinchem\/34.11.2372a","article-title":"Rapid isolation and detection of drugs in meconium of infants of drug\u2010dependent mothers","volume":"34","author":"Ostrea E.M.","year":"1988","journal-title":"Clin. Chem."},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200202000-00004"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2008.03.029"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/31.1.1"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1570-0232(03)00478-1"},{"key":"e_1_2_5_13_1","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1097\/01.ftd.0000245380.95186.13","article-title":"Quantification of Delta9\u2010tetrahydrocannabinol and its major metabolites in meconium by gas chromatographic\u2010mass spectrometric assay: Assay validation and preliminary results of the \u201cmeconium project\u201d","volume":"28","author":"Marchei E.","year":"2006","journal-title":"Ther. Drug Monit."},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(98)70059-9"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-009-2680-5"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-010-3942-y"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntr069"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0379-0738(02)00160-3"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2006.09.012"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-011-1122-4"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39140.394410.DB"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2010.10400685"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e31822724f0"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2010.154864"},{"key":"e_1_2_5_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2009.09.021"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e3181d0bd68"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e3181dca48b"},{"key":"e_1_2_5_28_1","doi-asserted-by":"publisher","DOI":"10.1136\/fn.88.2.F98"},{"key":"e_1_2_5_29_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.4526"}],"container-title":["Drug Testing and Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fdta.1459","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/dta.1459","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T19:13:07Z","timestamp":1760382787000},"score":1,"resource":{"primary":{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/10.1002\/dta.1459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,6]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["10.1002\/dta.1459"],"URL":"https:\/\/doi.org\/10.1002\/dta.1459","archive":["Portico"],"relation":{},"ISSN":["1942-7603","1942-7611"],"issn-type":[{"value":"1942-7603","type":"print"},{"value":"1942-7611","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,6]]}}}